Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/20023
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGold, Grace-
dc.contributor.authorGoh, Su Kah-
dc.contributor.authorChristophi, Christopher-
dc.contributor.authorMuralidharan, Vijayaragavan-
dc.date2018-11-20-
dc.date.accessioned2019-01-02T01:14:45Z-
dc.date.available2019-01-02T01:14:45Z-
dc.date.issued2018-11-20-
dc.identifier.citationInternational journal of surgery case reports 2018; 54: 20-22-
dc.identifier.issn2210-2612-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/20023-
dc.description.abstractSerum carbohydrate antigen 19-9 (CA19-9) is routinely used in the management of pancreatic cancer for diagnosis, prognostication and surveillance purposes despite its low specificity. This case report demonstrates the challenges of interpreting elevated serum CA19.9 levels in a patient with pancreatic cancer. We performed a Whipple's procedure in an otherwise fit 78-year-old man for pancreatic adenocarcinoma. One year after surgery, he presented with a non-malignant anastomotic stricture that was associated with an elevated serum CA19-9. Subsequently, he presented with biliary sepsis secondary to an infected liver cyst. CA19-9 in the cyst fluid and serum were elevated. On both of these occasions, serum CA19-9 normalised without any clinical or radiological evidence of recurrence. Despite sound clinical acumen and investigations, it may be hard to differentiate cancer recurrence from benign aetiologies. Benign conditions may cause elevation of CA19-9, even in the setting of previous malignancy. Persistently high CA19-9 level post-decompression raises suspicion of malignancy. This case serves as a reminder for clinicians that non-specific increases in CA19-9 after curative surgery is not uncommon. We recommend careful interpretation of CA19-9 levels in combination with clinical history, physical examination and radiological investigations.-
dc.language.isoeng-
dc.subjectCA19-9-
dc.subjectCase report-
dc.subjectGeneral surgery-
dc.subjectHepatopancreatobiliary surgery-
dc.subjectPancreatic cancer-
dc.subjectTumour marker-
dc.titleDilemmas and limitations interpreting carbohydrate antigen 19-9 elevation after curative pancreatic surgery: A case report.-
dc.typeJournal Article-
dc.identifier.journaltitleInternational journal of surgery case reports-
dc.identifier.affiliationDepartment of Hepato-Pancreatic-Biliary Surgery, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationVictorian Liver Transplant Unit, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.doi10.1016/j.ijscr.2018.11.022-
dc.identifier.orcid0000-0002-4001-4912-
dc.identifier.orcid0000-0002-6684-2521-
dc.identifier.orcid0000-0001-8247-8937-
dc.identifier.pubmedid30513493-
dc.type.austinJournal Article-
local.name.researcherChristophi, Christopher
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptHepatopancreatobiliary Surgery-
crisitem.author.deptSurgery (University of Melbourne)-
crisitem.author.deptSurgery-
crisitem.author.deptHepatopancreatobiliary Surgery-
crisitem.author.deptSurgery (University of Melbourne)-
crisitem.author.deptHepatopancreatobiliary Surgery-
crisitem.author.deptSurgery-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

34
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.